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Long-term prognostic implications of visit-to-visit blood pressure variability in patients with  
ischaemic stroke 
KK Lau, YK Wong, KC Teo, RSK Chang, KH Chan, SFK Hon, KL Wat, RTF Cheung, LSW Li, CW Siu, SL Ho, HF Tse
Department of Medicine, The University of Hong Kong, Hong Kong
Background: Both blood pressure (BP) and its variability (BPV) are established risk factors for the development 
of atherosclerotic diseases and are associated with an increased risk of cardiovascular and all-cause mortality. 
The long-term prognostic implications of out-patient clinic visit-to-visit BPV among patients with ischaemic 
stroke are nevertheless unknown. 
Methods: We prospectively followed up the clinical outcome of 632 consecutive ischaemic stroke patients 
without atrial fibrillation. The mean BP and BPV, as determined by the coefficient of variation of the systolic and 
diastolic BP, were recorded during a mean of 12 ± 6 outpatient clinic visits. 
Results: The mean age of the patients was 71 ± 11 years. After a mean of 76 ± 18 month’s follow-up, 161 (26%) 
patients died, 35% (56/161) were due to cardiovascular causes. 16% and 5% developed recurrent stroke and 
acute coronary syndrome (ACS), respectively. After adjusting for mean systolic BP and confounding variables, 
patients with a high systolic BPV were at significantly greater risk of cardiovascular mortality (hazard ratio [HR] 
= 2.36; 95% confidence interval [CI], 1.02-5.49; P < 0.05). A high systolic BPV also predicted all-cause mortality 
after adjusting for mean systolic BP (HR = 1.79; 95% CI, 1.16-2.75; P < 0.05). There was no association between 
systolic BPV with non-fatal recurrent stroke nor non-fatal ACS. A raised diastolic BPV did not predict recurrent 
non-fatal stroke, non-fatal ACS nor mortality. 
Conclusions: Visit-to-visit systolic BPV predicts long-term all-cause and cardiovascular mortality in patients with 
ischaemic stroke without atrial fibrillation, independent of other conventional risk factors including average BP 
control. 
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Mediterranean diet reduces blood pressure variability and subsequent stroke risk in patients  
with coronary artery disease
KK Lau, YK Wong, YH Chan, OY Li, LSW Li, CW Siu, SL Ho, HF Tse
Department of Medicine, The University of Hong Kong, Hong Kong
Introduction: The Mediterranean diet has been widely advocated for the prevention of cardiovascular and 
cerebrovascular diseases. Meanwhile, visit-to-visit blood pressure variability (BPV) is a novel risk factor for 
the development of atherosclerotic diseases. However, whether diet plays a role in modulating BPV remains 
uncertain. We investigated whether the Mediterranean diet is associated with BPV and subsequent prognosis 
in patients with coronary artery disease (CAD). 
Methods: A total of 274 consecutive patients with stable CAD were recruited in 2005-2006. All patients underwent 
a food frequency questionnaire (FFQ) to delineate their dietary intake within the past 5 years. A Mediterranean 
Diet Score was derived based on components within the FFQ (a higher score reflecting more components of 
the Mediterranean diet being taken). Patients were followed up regularly every 3-4 months and their blood 
pressure measured during each visit. The development of acute coronary syndrome (ACS), heart failure 
requiring hospitalisation, stroke and cardiovascular mortality during the follow-up period was monitored. 
Results: After a mean follow-up of 77 ± 12 months, 20 (7.3% of the study population), 29 (10.6%), 13 (4.7%), and 
19 (6.9%) patients developed ACS, heart failure, stroke, and cardiovascular mortality, respectively. Patients 
who developed a stroke had a significantly lower Mediterranean Diet Score (1.7 ± 0.5 vs 2.6 ± 1.1; P < 0.01) and 
significantly higher visit-to-visit BPV (systolic blood pressure standard deviation 20 ± 9 mm Hg vs 14 ± 5 mm 
Hg; P = 0.03) compared to those who did not develop stroke. There were no differences in Mediterranean 
Diet Score among patients who did and did not develop ACS, heart failure, and cardiovascular mortality. A low 
Mediterranean Diet Score independently predicted a raised systolic BPV (B, -0.61; 95% confidence interval [CI], 
-1.16 to -0.07; P = 0.03). After adjustment for confounding variables, a higher Mediterranean Diet Score reduced 
the subsequent risk of stroke (hazard ratio [HR] = 0.34; 95% CI, 0.15-0.75; P < 0.01) whilst a high systolic BPV 
significantly increased the risk of stroke (HR = 1.13; 95% CI 1.03-1.24; P = 0.01).
Conclusion: In patients with CAD, adopting a Mediterranean diet reduces BPV and subsequent stroke risk. 
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